ADVFN US – Market Content Editor
-
TD SYNNEX Beats Estimates For Q2 but Shares Drop 2%
TD SYNNEX Corp. (NYSE:SNX) reported stronger-than-expected results for the second quarter on Tuesday, yet its shares fell 2% in response. The IT distributor posted adjusted earnings per share (EPS) of $2.99, beating analyst expectations of $2.71. Revenue rose 7.2% year-over-year to $14.95 billion, surpassing the forecasted $14.3 billion. “Our Q2 results demonstrate the continued strength…
-
BlackSky Stock Jumps 6% After Securing $24 Million NGA Monitoring Contract
BlackSky Technology Inc. (NYSE:BKSY) shares climbed 6% following the award of a delivery order valued at over $24 million from the National Geospatial-Intelligence Agency (NGA) for facility operational monitoring services. The four-year contract requires BlackSky to provide AI-enabled object detection and pattern-of-life change monitoring at military and economic facilities worldwide. The company has already received…
-
OS Therapies Stock Surges 12.4% After Positive FDA Feedback on OST-HER2
OS Therapies Inc (NYSE-A:OSTX) shares jumped 12.4% following favorable feedback from the FDA regarding its OST-HER2 treatment for osteosarcoma. The clinical-stage biopharmaceutical company announced it received positive written input from a mid-June FDA Type D Meeting concerning the endpoints needed to support an Accelerated Approval Program marketing application for its Phase 2b trial. This trial…
-
Amarin Stock Surges 11% After $25 Million Licensing Deal with Recordati
Amarin Corporation PLC (NASDAQ:AMRN) shares jumped 11% following the announcement of an exclusive long-term licensing and supply agreement with Italian pharmaceutical company Recordati S.p.A. (BIT: RECI) for its cardiovascular drug VAZKEPA in Europe. As part of the deal, Amarin will receive $25 million upfront, with the potential to earn up to $150 million in milestone…
-
iBio Stock Surges 50% After Promising Preclinical Data on Amylin Receptor Antibody
iBio Inc (NASDAQ:IBIO) shares jumped 50% following the announcement of preclinical results showing its engineered amylin receptor agonist antibody reduced acute food intake by 60% in a mouse model of obesity. The AI-driven biotech company revealed that its partnership with AstralBio has produced multiple novel engineered antibody agonists targeting the amylin receptor, a heterodimeric G…
-
Krispy Kreme Stock Declines After Ending Partnership with McDonald’s
Krispy Kreme, Inc. (NASDAQ:DNUT) shares dropped as much as 7% before recovering slightly to close down 4% on Tuesday, following the announcement that the doughnut company and McDonald’s USA (NYSE:MCD) will end their partnership effective July 2, 2025. The two companies said the decision was mutual after determining the business model was not financially sustainable…
-
Nektar Therapeutics Shares Surge 140% After Atopic Dermatitis Drug Meets Key Study Goals
Nektar Therapeutics (NASDAQ:NKTR) saw its stock soar 140% following promising Phase 2b trial results for its experimental treatment rezpegaldesleukin in moderate-to-severe atopic dermatitis. The biotech company reported that all three dosage groups of rezpegaldesleukin achieved statistically significant improvements in the primary endpoint, which measured the average percentage change in EASI scores at week 16 versus…
-
Nano Labs Shares Surge Following $500 Million Convertible Notes Placement and Crypto Acquisition Plans
Nano Labs (NASDAQ:NA), a provider of Web 3.0 infrastructure, saw its stock price jump 200% after announcing a private placement of $500 million in convertible notes alongside plans to invest significantly in the cryptocurrency BNB. The company, headquartered in China, entered into an agreement with multiple investors to issue convertible promissory notes that mature in…
-
Array Technologies Shares Drop Following Announcement of $250 Million Convertible Notes Offering
Array Technologies Inc. (NASDAQ:ARRY) saw its stock decline by 12% on Thursday after the company revealed plans to issue $250 million worth of convertible senior notes due in 2031 through a private placement aimed at qualified institutional investors. The solar tracking systems provider explained that these notes will be senior unsecured debt with interest paid…
-
Uber Shares Climb Following Launch of Waymo Autonomous Rides in Atlanta
Uber Technologies Inc (NYSE:UBER) saw its stock gain 2.75% in premarket trading on Tuesday, following the announcement that it has expanded its autonomous ride services to Atlanta in collaboration with Waymo. From today onward, residents of Atlanta can request a Waymo autonomous vehicle directly through the Uber app. This new service builds on the existing…